Cargando…

Evaluating Serum Heat Shock Protein Levels as Novel Biomarkers for Atrial Fibrillation

Background: Staging of atrial fibrillation (AF) is essential to understanding disease progression and the accompanied increase in therapy failure. Blood-based heat shock protein (HSP) levels may enable staging of AF and the identification of patients with higher risk for AF recurrence after treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Marion, Denise M. S., Lanters, Eva A. H., Ramos, Kennedy S., Li, Jin, Wiersma, Marit, Baks-te Bulte, Luciënne, J. Q. M. Muskens, Agnes, Boersma, Eric, de Groot, Natasja M. S., Brundel, Bianca J. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564530/ https://www.ncbi.nlm.nih.gov/pubmed/32947824 http://dx.doi.org/10.3390/cells9092105

Ejemplares similares

Daily Supplementation of L-Glutamine in Atrial Fibrillation Patients: The Effect on Heat Shock Proteins and Metabolites
por: Starreveld, Roeliene, et al.
Publicado: (2020)

Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2020)

DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD(+) depletion in experimental atrial fibrillation
por: Zhang, Deli, et al.
Publicado: (2019)

The protective role of small heat shock proteins in cardiac diseases: key role in atrial fibrillation
por: Hu, Xu, et al.
Publicado: (2017)

The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line
por: Lanters, E.A.H., et al.
Publicado: (2015)

Mitochondrial Dysfunction Underlies Cardiomyocyte Remodeling in Experimental and Clinical Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2019)

Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
por: Li, Jin, et al.
Publicado: (2022)

HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation
por: Lanters, Eva A. H., et al.
Publicado: (2015)

The Antibiotic Doxycycline Impairs Cardiac Mitochondrial and Contractile Function
por: Wüst, Rob C. I., et al.
Publicado: (2021)

Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target
por: van Wijk, Stan W., et al.
Publicado: (2021)

The Genetic Puzzle of Familial Atrial Fibrillation
por: Ragab, Ahmed A. Y., et al.
Publicado: (2020)

RhoA Activation Sensitizes Cells to Proteotoxic Stimuli by Abrogating the HSF1-Dependent Heat Shock Response
por: Meijering, Roelien A. M., et al.
Publicado: (2015)

The Role of Mitochondrial Dysfunction in Atrial Fibrillation: Translation to Druggable Target and Biomarker Discovery
por: Pool, Lisa, et al.
Publicado: (2021)

Atrial fibrillation: A never ending story?
por: Lanters, Eva A. H., et al.
Publicado: (2019)

Atrial fibrillation fingerprinting; spotting bio‐electrical markers to early recognize atrial fibrillation by the use of a bottom‐up approach (AFFIP): Rationale and design
por: Starreveld, Roeliene, et al.
Publicado: (2020)

Role of Autophagy in Proteostasis: Friend and Foe in Cardiac Diseases
por: Li, Jin, et al.
Publicado: (2018)

Imbalance of ER and Mitochondria Interactions: Prelude to Cardiac Ageing and Disease?
por: Li, Jin, et al.
Publicado: (2019)

DNA Damage, an Innocent Bystander in Atrial Fibrillation and Other Cardiovascular Diseases?
por: Ramos, Kennedy S., et al.
Publicado: (2020)

The Impact of Filter Settings on Morphology of Unipolar Fibrillation Potentials
por: Starreveld, Roeliene, et al.
Publicado: (2020)

Loss of Proteostatic Control as a Substrate for Atrial Fibrillation: A Novel Target for Upstream Therapy by Heat Shock Proteins
por: Meijering, Roelien A. M., et al.
Publicado: (2012)

Degree of Fibrosis in Human Atrial Tissue Is Not the Hallmark Driving AF
por: S. Ramos, Kennedy, et al.
Publicado: (2022)

Endoplasmic Reticulum Stress Is Associated With Autophagy and Cardiomyocyte Remodeling in Experimental and Human Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2017)

Editorial: Innovative Approaches to Tackle Atrial Fibrillation: From Bench to Bedside
por: Ai, Xun, et al.
Publicado: (2020)

Early markers of atrial fibrillation recurrence after pulmonary vein isolation
por: Lanters, Eva A. H., et al.
Publicado: (2020)

Intraoperative Inducibility of Atrial Fibrillation Does Not Predict Early Postoperative Atrial Fibrillation
por: Lanters, Eva A. H., et al.
Publicado: (2018)

Cytoskeletal Protein Variants Driving Atrial Fibrillation: Potential Mechanisms of Action
por: van Wijk, Stan W., et al.
Publicado: (2022)

Prevention of Atrial Fibrillation: Putting Proteostasis Derailment Back on Track
por: Kishore, Preetam, et al.
Publicado: (2023)

Untying the knot: protein quality control in inherited cardiomyopathies
por: Dorsch, Larissa M., et al.
Publicado: (2018)

Dissecting the Molecular Mechanisms Driving Electropathology in Atrial Fibrillation: Deployment of RNA Sequencing and Transcriptomic Analyses
por: Huiskes, Fabries G., et al.
Publicado: (2023)

Sinus Rhythm Conduction Properties across Bachmann’s Bundle: Impact of Underlying Heart Disease and Atrial Fibrillation
por: Teuwen, Christophe P., et al.
Publicado: (2020)

Aberrant coronary artery spasms cause ST‐T segment depression during endovascular ablation of atrial flutter
por: Lanters, Eva A. H., et al.
Publicado: (2017)

Epicardial Electric Activation During Atrial Fibrillation
por: Kharbanda, Rohit K., et al.
Publicado: (2020)

Characterization of unipolar electrogram morphology: a novel tool for quantifying conduction inhomogeneity
por: Ye, Ziliang, et al.
Publicado: (2023)

Therapeutic options for patients with advanced atrial fibrillation: from lifestyle and medication to catheter and surgical ablation
por: Boersma, L., et al.
Publicado: (2020)

Autoimmunity-related atrial fibrillation incidence: an emerging conundrum meriting further investigation: authors’ reply
por: Tilly, Martijn J, et al.
Publicado: (2023)

QUest for the Arrhythmogenic Substrate of Atrial fibRillation in Patients Undergoing Cardiac Surgery (QUASAR Study): Rationale and Design
por: van der Does, Lisette J. M. E., et al.
Publicado: (2016)

Direction‐ and rate‐dependent fractionation during atrial fibrillation persistence: Unmasking cardiac anisotropy?
por: Starreveld, Roeliene, et al.
Publicado: (2020)

The Role of Proteostasis Derailment in Cardiac Diseases
por: Brundel, Bianca J. J. M.
Publicado: (2020)

Exploring Refractoriness as an Adjunctive Electrical Biomarker for Staging of Atrial Fibrillation
por: van Staveren, Lianne N., et al.
Publicado: (2020)

Detection of atrial fibrillation-related electropathology by artificial intelligence: is the future already here?( )
por: de Groot, Natasja M S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8l83m827t959qg08ui5ulkqha